The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Alessio Crippa; Bram De Laere; Andrea Discacciati; Berit Larsson; Jason T. Connor; Erin E. Gabriel; Camilla Thellenberg; Elin Janes; Gunilla Enblad; Anders Ullen; Marie Hjalm-Eriksson; Jan Oldenburg; Piet Ost; Johan Lindberg; Martin Eklund; Henrik Gronberg

doi:10.1186/s13063-020-04515-8

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Alessio Crippa
, Bram De Laere
, Andrea Discacciati
, Berit Larsson
, Jason T. Connor
, Erin E. Gabriel
, Camilla Thellenberg
, Elin Janes
, Gunilla Enblad
, Anders Ullen
, Marie Hjalm-Eriksson
, Jan Oldenburg
, Piet Ost
, Johan Lindberg
, Martin Eklund
, Henrik Gronberg

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

1 Downloads (Pure)

Originalsprog	Engelsk
Artikelnummer	579
Tidsskrift	Trials
Vol/bind	21
Antal sider	10
ISSN	1745-6215
DOI	https://doi.org/10.1186/s13063-020-04515-8
Status	Udgivet - 2020
Udgivet eksternt	Ja

Adgang til dokumentet

10.1186/s13063-020-04515-8Licens: CC BY

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

Crippa, A., De Laere, B., Discacciati, A., Larsson, B., Connor, J. T., Gabriel, E. E., Thellenberg, C., Janes, E., Enblad, G., Ullen, A., Hjalm-Eriksson, M., Oldenburg, J., Ost, P., Lindberg, J., Eklund, M., & Gronberg, H. (2020). The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer. Trials, 21, Artikel 579. https://doi.org/10.1186/s13063-020-04515-8

Crippa, A, De Laere, B, Discacciati, A, Larsson, B, Connor, JT, Gabriel, EE, Thellenberg, C, Janes, E, Enblad, G, Ullen, A, Hjalm-Eriksson, M, Oldenburg, J, Ost, P, Lindberg, J, Eklund, M & Gronberg, H 2020, 'The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer', Trials, bind 21, 579. https://doi.org/10.1186/s13063-020-04515-8

@article{25f1352419be459e8a7564fcccca3e1b,

title = "The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer",

keywords = "Clinical trial platform, Genetic biomarker, Prostate cancer, Precision medicine",

author = "Alessio Crippa and \{De Laere\}, Bram and Andrea Discacciati and Berit Larsson and Connor, \{Jason T.\} and Gabriel, \{Erin E.\} and Camilla Thellenberg and Elin Janes and Gunilla Enblad and Anders Ullen and Marie Hjalm-Eriksson and Jan Oldenburg and Piet Ost and Johan Lindberg and Martin Eklund and Henrik Gronberg",

year = "2020",

doi = "10.1186/s13063-020-04515-8",

language = "English",

volume = "21",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

}

TY - JOUR

T1 - The ProBio trial

T2 - molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

AU - Crippa, Alessio

AU - De Laere, Bram

AU - Discacciati, Andrea

AU - Larsson, Berit

AU - Connor, Jason T.

AU - Gabriel, Erin E.

AU - Thellenberg, Camilla

AU - Janes, Elin

AU - Enblad, Gunilla

AU - Ullen, Anders

AU - Hjalm-Eriksson, Marie

AU - Oldenburg, Jan

AU - Ost, Piet

AU - Lindberg, Johan

AU - Eklund, Martin

AU - Gronberg, Henrik

PY - 2020

Y1 - 2020

KW - Clinical trial platform

KW - Genetic biomarker

KW - Prostate cancer

KW - Precision medicine

U2 - 10.1186/s13063-020-04515-8

DO - 10.1186/s13063-020-04515-8

M3 - Journal article

SN - 1745-6215

VL - 21

JO - Trials

JF - Trials

M1 - 579

ER -